Erin Creighton, MD
Sleep Medicine · Little Rock, ARNPI 1821594409
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (55.5%), travel and lodging and education — rather than concentrated in one kind of arrangement. Inspire Medical Systems, Inc. accounts for 75.2% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2024 at $2,142 and has fallen 71.3% since, to $615 in 2025.
Across 41 payments — averaging $85.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Inspire Medical Systems, Inc.$3K
- Jazz Pharmaceuticals Inc.$374
- Regeneron Healthcare Solutions, Inc.$205
- ZOLL Respicardia, Inc.$123
- GSK$97
- Medtronic$73
What the payments were for
- Travel & lodging$1,47442%
- Food & beverage$1,94855%
- Education$893%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Inspire Medical Systems, Inc. | 26 | $2,640 |
| Jazz Pharmaceuticals Inc. | 3 | $374 |
| Regeneron Healthcare Solutions, Inc. | 5 | $205 |
| ZOLL Respicardia, Inc. | 1 | $123 |
| GSK | 5 | $97 |
| Medtronic | 1 | $73 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Inspire$2,308
- remede System$123
- XYWAV$120
How this compares
Too few sleep medicine providers in Arkansasto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Azelastine Hcl | 45 | $856 |
| Fluticasone Propionate | 36 | $447 |
| Omeprazole | 23 | $384 |
| Ipratropium Bromide | 14 | $336 |
| Famotidine | 29 | $193 |
Paid to pharmacies, not to this prescriber.
Other sleep medicine in Little Rock
- Jason WilliamsLittle Rock$5K
- David DavilaLittle Rock$5K
- Gary GozaLittle Rock$3K
- Khaled KhasawnehLittle Rock$621
- Nanjunda PrabhaBatesville$4K
- Julie AllenSearcy$4K
- Dimitry FominRogers$4K
- Erica WilliamsSearcy$2K
- Michael EcklesFayetteville$2K
- David AndersonConway$0
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.